September 2021 Archive
TTUHSC Technology Leads Successful Clinical Trial to Treat Dry Eye Disease
Hironmoy Das, Ph.D., a professor of pharmaceutical sciences at the Texas Tech University Health Sciences Center (TTUHSC) Jerry H. Hodge School of Pharmacy, developed a technology derived from corneal epithelial stem cells to improve outcomes for DED patients.
Study Could Lead to New Treatments for Neuroblastoma
In previous research, a team of investigators led by C. Patrick Reynolds, M.D., Ph.D., director of the Texas Tech University Health Sciences Center (TTUHSC) School of Medicine Cancer Center, began studying the potential for using the ways cancer cells maintain telomeres — the protective caps on the end of chromosomes — to attack certain cancer cells.
Tags
- #Abilene
- #Administration
- #Alumni
- #Amarillo
- #Breast Center of Excellence
- #Campus Life
- #COVID-19
- #Dallas
- #Development
- #Diversity
- #Education
- #Emergency
- #Events
- #F. Marie Hall Institute for Rural and Community Health
- #F. Marie Hall SimLife Center
- #Faculty
- #Feature Stories
- #Garrison Institute on Aging
- #General
- #Graduate School of Biomedical Sciences
- #Health
- #Hispanic-Serving Institution
- #Laura W. Bush Institute for Women's Health
- #Lubbock
- #Managed Care
- #Mental Health Initiative
- #Mental Health Resource Hub
- #Military
- #Miscellaneous
- #News Releases
- #Paul L. Foster School of Medicine
- #Permian Basin
- #President
- #Public Art
- #Research
- #School of Health Professions
- #School of Medicine
- #School of Nursing
- #School of Pharmacy
- #School of Population and Public Health
- #Staff
- #Statline
- #Stories
- #Students
- #Team Member Spotlight
- #Texas Tech Physicians
- #The Free Clinic
- #TTUHSC in the News
- #Values
- #Videos
- #Vision
- #Well Beyond
- #Women's Health